| Karen Brixon-holloway, FNP | |
|
120 Health Center Dr, Ahoskie, NC 27910-8161 | |
| (252) 332-3548 | |
| (252) 332-1665 |
| Full Name | Karen Brixon-holloway |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 120 Health Center Dr, Ahoskie, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629684642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 162986 (North Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 501630 (North Carolina) | Primary |
| Entity Name | Roanoke Chowan Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790851004 PECOS PAC ID: 7214983386 Enrollment ID: O20050428001071 |
News Archive
Clostridium difficile is a bacterium that has killed thousands abroad. Now is has been detected in three Australians for the first time. The bacterium was detected in three patients at Melbourne's Epworth Hospital.
Houston Chronicle: "Texas scores high in emergency preparedness during a time when many other states are suffering cuts in state and federal public health funding and losses in medical staff, according to the Ready or Not? report, sponsored by Trust for America's Health, a disease prevention advocacy group, and the Robert Wood Johnson Foundation." But, economic turmoil has led to a "nationwide backslide in overall emergency preparedness" (Burton, 12/15).
ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).
With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 men diagnosed with prostate cancer conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Brixon-holloway, FNP Po Box 669, Ahoskie, NC 27910-0669 Ph: (252) 209-0237 | Karen Brixon-holloway, FNP 120 Health Center Dr, Ahoskie, NC 27910-8161 Ph: (252) 332-3548 |
News Archive
Clostridium difficile is a bacterium that has killed thousands abroad. Now is has been detected in three Australians for the first time. The bacterium was detected in three patients at Melbourne's Epworth Hospital.
Houston Chronicle: "Texas scores high in emergency preparedness during a time when many other states are suffering cuts in state and federal public health funding and losses in medical staff, according to the Ready or Not? report, sponsored by Trust for America's Health, a disease prevention advocacy group, and the Robert Wood Johnson Foundation." But, economic turmoil has led to a "nationwide backslide in overall emergency preparedness" (Burton, 12/15).
ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).
With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 men diagnosed with prostate cancer conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 5 days ago
Mrs. Susan T Hoggard, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 201 Colony Ave S, Ahoskie, NC 27910 Phone: 252-332-5041 Fax: 252-332-6115 | |
Renita Deloatch Smallwood, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 500 Academy St S, Ahoskie, NC 27910 Phone: 252-209-3385 | |
Jordan Alexandra Conner, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 226 Academy St S, Ahoskie, NC 27910 Phone: 252-209-3911 | |
Mr. Calvin B Parker Jr., AGPCNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 925 Liverman Mill Rd, Ahoskie, NC 27910 Phone: 252-642-3174 | |
Angela Miller, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 120 Health Center Dr, Ahoskie, NC 27910 Phone: 252-332-3548 Fax: 252-332-1665 | |
Carla Dee Cooper Eure, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 120 Health Center Dr, Ahoskie, NC 27910 Phone: 252-332-3548 | |
Mrs. Mary Kathleen Boone Perry, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 602 Academy St S, Ahoskie, NC 27910 Phone: 252-332-3699 Fax: 252-332-4335 |